204 related articles for article (PubMed ID: 14694955)
1. Cardiomyopathy in congenital disorders of glycosylation.
Gehrmann J; Sohlbach K; Linnebank M; Böhles HJ; Buderus S; Kehl HG; Vogt J; Harms E; Marquardt T
Cardiol Young; 2003 Aug; 13(4):345-51. PubMed ID: 14694955
[TBL] [Abstract][Full Text] [Related]
2. Severe transient myocardial ischaemia caused by hypertrophic cardiomyopathy in a patient with congenital disorder of glycosylation type Ia.
Marquardt T; Hülskamp G; Gehrmann J; Debus V; Harms E; Kehl HG
Eur J Pediatr; 2002 Oct; 161(10):524-7. PubMed ID: 12297897
[TBL] [Abstract][Full Text] [Related]
3. Congenital disorders of glycosylation type Ia as a cause of mirror syndrome.
Wurm D; Löffler G; Lindinger A; Gortner L
J Perinatol; 2007 Dec; 27(12):802-4. PubMed ID: 18034167
[TBL] [Abstract][Full Text] [Related]
4. Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease.
Scaglia F; Towbin JA; Craigen WJ; Belmont JW; Smith EO; Neish SR; Ware SM; Hunter JV; Fernbach SD; Vladutiu GD; Wong LJ; Vogel H
Pediatrics; 2004 Oct; 114(4):925-31. PubMed ID: 15466086
[TBL] [Abstract][Full Text] [Related]
5. Intracranial hemorrhage as the initial manifestation of a congenital disorder of glycosylation.
Cohn RD; Eklund E; Bergner AL; Casella JF; Woods SL; Althaus J; Blakemore KJ; Fox HE; Hoover-Fong JE; Hamosh A; Braverman NE; Freeze HH; Boyadjiev SA
Pediatrics; 2006 Aug; 118(2):e514-21. PubMed ID: 16816004
[TBL] [Abstract][Full Text] [Related]
6. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children.
Decker JA; Rossano JW; Smith EO; Cannon B; Clunie SK; Gates C; Jefferies JL; Kim JJ; Price JF; Dreyer WJ; Towbin JA; Denfield SW
J Am Coll Cardiol; 2009 Jul; 54(3):250-4. PubMed ID: 19589438
[TBL] [Abstract][Full Text] [Related]
7. Sudden unexpected death in children with a previously diagnosed cardiovascular disorder.
Polderman FN; Cohen J; Blom NA; Delhaas T; Helbing WA; Lam J; Sobotka-Plojhar MA; Temmerman AM; Sreeram N
Int J Cardiol; 2004 Jun; 95(2-3):171-6. PubMed ID: 15193816
[TBL] [Abstract][Full Text] [Related]
8. Clinical profiles and outcomes for Omani children with dilated cardiomyopathy seen in a regional referral hospital.
Jaiyesimi O; Kasem M
Cardiol Young; 2009 Apr; 19(2):145-51. PubMed ID: 19224668
[TBL] [Abstract][Full Text] [Related]
9. Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death.
Basso C; Thiene G; Mackey-Bojack S; Frigo AC; Corrado D; Maron BJ
Eur Heart J; 2009 Jul; 30(13):1627-34. PubMed ID: 19406869
[TBL] [Abstract][Full Text] [Related]
10. Idiopathic dilated cardiomyopathy: prognostic significance of electrocardiographic and electrophysiologic findings in the nineties.
Morgera T; Di Lenarda A; Sabbadini G; Rakar S; Carniel E; Driussi M; Sinagra G
Ital Heart J; 2004 Aug; 5(8):593-603. PubMed ID: 15554030
[TBL] [Abstract][Full Text] [Related]
11. Cardiomyopathies in children with neuromuscular disorders.
Malcić I; Barisić N; Brzović Z; Pazanin L; Senecić I
Neurol Croat; 1991; 40(4):221-30. PubMed ID: 1751640
[TBL] [Abstract][Full Text] [Related]
12. Cardiac manifestations of inborn errors of metabolism.
Evangeliou A; Papadopoulou-Legbelou K; Daphnis E; Ganotakis E; Vavouranakis I; Michailidou H; Hitoglou-Makedou A; Nicolaidou P; Wevers R; Varlamis G
Minerva Pediatr; 2007 Jun; 59(3):215-8. PubMed ID: 17519866
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry.
Colan SD; Lipshultz SE; Lowe AM; Sleeper LA; Messere J; Cox GF; Lurie PR; Orav EJ; Towbin JA
Circulation; 2007 Feb; 115(6):773-81. PubMed ID: 17261650
[TBL] [Abstract][Full Text] [Related]
14. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
[TBL] [Abstract][Full Text] [Related]
15. [Congenital disorders of glycosylation and project "Euroglycanet"].
Petković D; Bilić K; Ninković D; Cuk M; Fumić K; Barić I
Lijec Vjesn; 2007; 129(8-9):286-92. PubMed ID: 18198629
[TBL] [Abstract][Full Text] [Related]
16. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy.
Elliott PM; Gimeno JR; Tomé MT; Shah J; Ward D; Thaman R; Mogensen J; McKenna WJ
Eur Heart J; 2006 Aug; 27(16):1933-41. PubMed ID: 16754630
[TBL] [Abstract][Full Text] [Related]
17. [Hypertrophic obstructive cardiomyopathy in child. About two cases].
Thiam M; Ka S; Ndiaye R; Fall PD; Mbaye FK; Imbert P
Dakar Med; 2004; 49(3):215-7. PubMed ID: 15776621
[TBL] [Abstract][Full Text] [Related]
18. Sudden death and hypertrophic cardiomyopathy: a review.
Ly HQ; Greiss I; Talakic M; Guerra PG; Macle L; Thibault B; Dubuc M; Roy D
Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263
[TBL] [Abstract][Full Text] [Related]
19. Restoration of cardiac function by setting the ventricular pacing at a lower range in an infant with congenital complete atrioventricular block and dilated cardiomyopathy.
Chen CA; Chang CI; Wang JK; Lin MT; Chiu SN; Chiu HH; Wu MH
Int J Cardiol; 2008 Dec; 131(1):e38-40. PubMed ID: 17931722
[TBL] [Abstract][Full Text] [Related]
20. Mutation in the alpha-cardiac actin gene associated with apical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects.
Monserrat L; Hermida-Prieto M; Fernandez X; Rodríguez I; Dumont C; Cazón L; Cuesta MG; Gonzalez-Juanatey C; Peteiro J; Alvarez N; Penas-Lado M; Castro-Beiras A
Eur Heart J; 2007 Aug; 28(16):1953-61. PubMed ID: 17611253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
